pd 98059 has been researched along with arsenic trioxide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonati, A; Costanzo, A; Levrero, M; Lunghi, P | 1 |
| Bonati, A; Lo-Coco, F; Lunghi, P; Pelicci, P; Pelicci, PG; Tabilio, A | 1 |
| Li, A; Liu, Q; Wang, X; Ye, J; Zhou, J | 1 |
| Ahn, HS; Jang, JJ; Jung, HS; Kim, CJ; Kim, HS; Lee, MJ; Ryu, KH; Seoh, JY; Shin, HY | 1 |
| Aravena, C; Beltrán, AR; Cornejo, M; Díaz, ES; Guzmán-Gutiérrez, E; Leiva, A; Pardo, F; Ramírez, MA; Sobrevia, L; Torres, V | 1 |
5 other study(ies) available for pd 98059 and arsenic trioxide
| Article | Year |
|---|---|
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Benzamides; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Genes, Tumor Suppressor; Humans; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Nuclear Proteins; Oxides; Proteins; Tumor Protein p73; Tumor Suppressor Proteins | 2004 |
Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Humans; Kinetics; Leukemia, Promyelocytic, Acute; MAP Kinase Kinase 1; Membrane Potentials; Mitochondria; Oxides; RNA, Small Interfering; Transfection | 2005 |
Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Butadienes; Cell Survival; DNA; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Humans; Imidazoles; MAP Kinase Kinase 1; Nitriles; Oxides; p38 Mitogen-Activated Protein Kinases; Pyridines; Thymidine; Tissue Culture Techniques; Tumor Cells, Cultured | 2005 |
Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Fibroblast Growth Factor 2; Flavonoids; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Neuroblastoma; Neurons; Oxides; Phenotype; Sarcoma, Ewing | 2006 |
Potential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferation.
Topics: Amiloride; Analysis of Variance; Animals; Arsenic Trioxide; Arsenicals; Blotting, Western; Carbazoles; Cell Count; Cell Fractionation; Cell Proliferation; Dogs; Flavonoids; Fluorometry; Hydrogen-Ion Concentration; Imidazoles; Macrolides; Madin Darby Canine Kidney Cells; Oxides; Sodium-Hydrogen Exchangers | 2012 |